3,4-methylenedioxyamphetamine has been researched along with Flaccid Quadriplegia in 3 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drees, JC | 1 |
| Stone, JA | 1 |
| Wu, AH | 1 |
| Baxter, RT | 1 |
| Linn, A | 1 |
| Kogan, KL | 1 |
| Tyler, N | 1 |
| Turner, P | 1 |
3 other studies available for 3,4-methylenedioxyamphetamine and Flaccid Quadriplegia
| Article | Year |
|---|---|
Morbidity involving the hallucinogenic designer amines MDA and 2C-I.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Chromatography, Gas; Designer Drugs; Dimethoxyphenylethylamine | 2009 |
Sex counseling and the SCI patient.
Topics: Counseling; Family; Humans; Love; Male; Quadriplegia; Sex; Spinal Cord Injuries | 1978 |
The process of interpersonal adaptation between mothers and their cerebral palsied children.
Topics: Adaptation, Psychological; Affect; Age Factors; Cerebral Palsy; Child, Preschool; Female; Hemiplegia | 1974 |